News in Brief
Stax to the mAx? Pall launches single-use mAb harvesting tech
Pall Corporation has launched a monoclonal antibody clarification platform without centrifugation or process additives to support cell cultures of up to 2,000L.
News in Brief
Pall Corporation has launched a monoclonal antibody clarification platform without centrifugation or process additives to support cell cultures of up to 2,000L.
Antibody-drug conjugate (ADC) developers are at risk of aggregation issues caused by the hydrophobic nature of next-generation linker-payloads, says ADC Bio.
Emergent will transfer the upstream process for a former-Sanofi smallpox vaccine from a site in Austria to Massachusetts following US FDA approval.